MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
3.345
-0.065 (-1.91%)
Dec 29, 2025, 1:57 PM EST - Market open
MDxHealth Market Cap
MDxHealth has a market cap or net worth of $165.57 million as of December 29, 2025. Its market cap has increased by 49.63% in one year.
Market Cap
165.57M
Enterprise Value
222.20M
1-Year Change
49.63%
Ranking
Category
Stock Price
$3.35
Market Cap Chart
Since the IPO on May 12, 2017, MDxHealth's market cap has decreased from $269.23M to $165.57M, a decrease of -38.50%. That is a compound annual growth rate of -5.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 168.79M | 50.60% |
| Dec 31, 2024 | 112.07M | 4.24% |
| Dec 29, 2023 | 107.52M | 659,987.71% |
| Dec 29, 2022 | 16.29K | -99.98% |
| Dec 30, 2020 | 91.60M | 18.07% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| May 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.74B |
| Johnson & Johnson | 503.28B |
| AbbVie | 408.69B |
| UnitedHealth Group | 299.26B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 266.17B |
| Novo Nordisk | 232.28B |